Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast Episode 533: GBT Researching PNN for Kirlian Research (OTC: $GTCH) and Zuora (NYSE: $ZUO) Launches Collect #AI #ArtficialIntelligence

Wednesday, March 17, 2021

#AIEye #Podcast Episode 533: GBT Researching PNN for Kirlian Research (OTC: $GTCH) and Zuora (NYSE: $ZUO) Launches Collect #AI #ArtficialIntelligence

#AIEye #Podcast Episode 533: GBT Researching PNN for Kirlian Research (OTC: $GTCH) and Zuora (NYSE: $ZUO) Launches Collect #AI #ArtficialIntelligence

Global AI in #DrugDiscovery Market to Reach $12B in 2026

Point Roberts WA, Vancouver BC – March 17, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/031721-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/03171GTCH-ZUO.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (NYSE:ZUO)

GBT Technologies Inc. (OTC PINK:GTCH) is researching Probabilistic Neural Network (PNN) algorithms and techniques for Kirlian research. PNN is described as “a supervised artificial neural network.” The press release indicates that the “PNN method typically is a major time-consuming process,” and consequently “GBT plans to invest in optimization algorithms and memory management to maintain the training performance.” An excerpt reads:

The use of a PNN goal is to potentially reach a higher level of accuracy and robustness for Kirlian image processing, achieving advanced imaging categorization and conclusions that may provide health related information.

Today the company also published an update on its PCT application for its 3D Chip and Memory patent in Europe. According to that press release, the PCT application entered the regional phase in Europe on March 16, 2021, and it is expected that the European Patent Office will shortly issue a communication under Rule 161 EPC.

Zuora, Inc. (NYSE:ZUO) has today launched Zuora Collect AI, the latest addition to the company’s subscription management suite of applications. According to the press release, Zuora Collect AI “leverages machine learning from billions of dollars in transactions and Zuora’s decade of Subscription Economy® expertise to automate smart payment retries,” and “customers [of Collect AI] reported a revenue recovery increase of 10-20% and improved subscriber retention.” Sri Srinivasan, Chief Product and Engineering Officer at Zuora, commented:

"Zuora’s decade of expertise driving subscription businesses, while handling billions of data points, enables us to inject this intelligence directly into the product. Collect AI is a true expression of our unique value to the market. Our technology is constantly learning from the largest ecosystem and data set in the Subscription Economy to help our customers maximize returns from their subscription services."

Global AI in Drug Discovery Market to Reach $12B in 2026

A report published by Facts & Factors finds that the global AI in Drug Discovery market will grow from around $830 million in 2019 to about $12 billion 2026 with a compound annual growth rate (CAGR) of nearly 39 percent in the forecast period 2020-2026. An excerpt from the report summary reads:

An AI in Drug Discovery is used to identify targets, in silico drug design, drug development, predictive analytics, research risk assessment, clinical tracking and even more.

Machine learning may help maximize treatment by combining biological and clinical evidence with mathematical models and can be used to develop drug testing and probabilistic treatment applications. Computational deep learning research indicates this methodology should be helpful in finding complex models in results. Since biological and clinical data are diverse, deterministic [quantum] machine learning algorithms offer a reasonable opportunity to advance interpret them.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About GBT Technologies Inc.

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp

Disclosure: GTCH is a paid monthly featured AI stock Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com